These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32068070)

  • 21. Variant call concordance between two laboratory-developed, solid tumor targeted genomic profiling assays using distinct workflows and sequencing instruments.
    Hampel KJ; de Abreu FB; Sidiropoulos N; Peterson JD; Tsongalis GJ
    Exp Mol Pathol; 2017 Apr; 102(2):215-218. PubMed ID: 28192086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aneuploidy and oncoviruses.
    Taheri F; Goudarzi H; Faghihloo E
    Rev Med Virol; 2019 Nov; 29(6):e2076. PubMed ID: 31407416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible Human Papillomavirus 38 Contamination of Endometrial Cancer RNA Sequencing Samples in The Cancer Genome Atlas Database.
    Kazemian M; Ren M; Lin JX; Liao W; Spolski R; Leonard WJ
    J Virol; 2015 Sep; 89(17):8967-73. PubMed ID: 26085148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
    Zhu Z; Ihle NT; Rejto PA; Zarrinkar PP
    BMC Genomics; 2016 Jun; 17():455. PubMed ID: 27296290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.
    Van Allen EM; Robinson D; Morrissey C; Pritchard C; Imamovic A; Carter S; Rosenberg M; McKenna A; Wu YM; Cao X; Chinnaiyan A; Garraway L; Nelson PS
    Oncotarget; 2016 Aug; 7(33):52888-52899. PubMed ID: 27167109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection.
    Kou T; Kanai M; Kamada M; Nakatsui M; Matsumoto S; Okuno Y; Muto M
    Methods Mol Biol; 2018; 1825():413-424. PubMed ID: 30334215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
    Damodaran S; Berger MF; Roychowdhury S
    Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?
    Garinet S; Néou M; de La Villéon B; Faillot S; Sakat J; Da Fonseca JP; Jouinot A; Le Tourneau C; Kamal M; Luscap-Rondof W; Boeva V; Gaujoux S; Vidaud M; Pasmant E; Letourneur F; Bertherat J; Assié G
    J Mol Diagn; 2017 Sep; 19(5):776-787. PubMed ID: 28826610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
    do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
    Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Intersection of HPV Epidemiology, Genomics and Mechanistic Studies of HPV-Mediated Carcinogenesis.
    Mirabello L; Clarke MA; Nelson CW; Dean M; Wentzensen N; Yeager M; Cullen M; Boland JF; ; Schiffman M; Burk RD
    Viruses; 2018 Feb; 10(2):. PubMed ID: 29438321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpretation of EBV infection in pan-cancer genome considering viral life cycle: LiEB (Life cycle of Epstein-Barr virus).
    Song H; Lim Y; Im H; Bae JM; Kang GH; Ahn J; Baek D; Kim TY; Yoon SS; Koh Y
    Sci Rep; 2019 Mar; 9(1):3465. PubMed ID: 30837539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral integration in BK polyomavirus-associated urothelial carcinoma in renal transplant recipients: multistage carcinogenesis revealed by next-generation virome capture sequencing.
    Wang Y; Liu Y; Deng W; Fu F; Yan S; Yang H; Liu R; Geng J; Xu J; Wu Y; Ma J; Zhou J; Liu N; Jin Y; Xia R; Elias N; Lee RJ; Feldman AS; Blute ML; Colvin RB; Wu CL; Miao Y
    Oncogene; 2020 Aug; 39(35):5734-5742. PubMed ID: 32724161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a targeted gene sequencing panel for application to disparate cancers.
    McCabe MJ; Gauthier MA; Chan CL; Thompson TJ; De Sousa SMC; Puttick C; Grady JP; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas ML; Lord RV; Johns AL; Kohonen-Corish M; O'Toole SA; Clark J; Mueller SA; Gupta R; McCormack AI; Dinger ME; Cowley MJ;
    Sci Rep; 2019 Nov; 9(1):17052. PubMed ID: 31745186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach.
    Patel NM; Jo H; Eberhard DA; Yin X; Hayward MC; Stein MK; Hayes DN; Grilley-Olson JE
    Appl Immunohistochem Mol Morphol; 2019; 27(10):764-772. PubMed ID: 30102605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput sequencing technologies.
    Reuter JA; Spacek DV; Snyder MP
    Mol Cell; 2015 May; 58(4):586-97. PubMed ID: 26000844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Institutional implementation of clinical tumor profiling on an unselected cancer population.
    Sholl LM; Do K; Shivdasani P; Cerami E; Dubuc AM; Kuo FC; Garcia EP; Jia Y; Davineni P; Abo RP; Pugh TJ; van Hummelen P; Thorner AR; Ducar M; Berger AH; Nishino M; Janeway KA; Church A; Harris M; Ritterhouse LL; Campbell JD; Rojas-Rudilla V; Ligon AH; Ramkissoon S; Cleary JM; Matulonis U; Oxnard GR; Chao R; Tassell V; Christensen J; Hahn WC; Kantoff PW; Kwiatkowski DJ; Johnson BE; Meyerson M; Garraway LA; Shapiro GI; Rollins BJ; Lindeman NI; MacConaill LE
    JCI Insight; 2016 Nov; 1(19):e87062. PubMed ID: 27882345
    [No Abstract]   [Full Text] [Related]  

  • 39. Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Biology.
    Strahan R; Uppal T; Verma SC
    Viruses; 2016 Mar; 8(4):92. PubMed ID: 27043613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.
    De Paoli P; Carbone A
    Semin Cancer Biol; 2015 Oct; 34():70-80. PubMed ID: 25837157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.